The average one-year price target for Milestone Pharmaceuticals (NasdaqGS:MIST) has been revised to $6.73 / share. This is an increase of 76.00% from the prior estimate of $3.82 dated December 3, 2025 ...

It has been almost a year since Facebook announced its blockbuster acquisition of messaging start-up, WhatsApp. All the while, I've remained a bit skeptical over the hefty $22 billionprice tag, ...

Milestone Partners, a buyout firm based in Saint Davids, Penn., has closed on capital commitments totaling $230 million for its third fund. It had a target of $200 million. Milestone Partners ...

) has been revised to $1.02 / share. This is a decrease of 50.00% from the prior estimate of $2.04 dated November 14, 2025. The price target is an average of many targets provided by analysts. The ...

The average one-year price target for Milestone Scientific (NYSEAM:MLSS) has been revised to $2.04 / share. This is an increase of 23.08% from the prior estimate of $1.66 dated September 27, 2025. The ...

Target has entered a new frontier, a world of green long void of bullseye red: the state of Vermont. Vermont has long stood as the only state without a Target store, but that will change later this ...

Milestone’s commercial strategy includes deploying 60 representatives who will target between 10,000 and 15,000 high-volume prescribers, according to Jefferies’ research. The firm indicated that ...